Sealonix, a Bedford, MA-based developer of sealant products for abdominopelvic and orthopedic procedures, closed a $20m Series A financing.
The round was led by Excelestar Ventures with participation from AMED Ventures, Sparta Group, Iyengar Capital, J2 Ventures and TiE Boston. Tasneem Dohadwala, Founding Partner at Excelestar Ventures, will be joining Sealonix’s Board of Directors.
The company intends to use the funds to grow the development team and execute clinical trials.
Founded in January 2023 by Amar Sawhney, CEO, Sealonix is using its biomaterials expertise to develop next generation hemostatic sealants for surgical use. The initial product is a sealant patch providing rapid hemostasis for abdominopelvic and orthopedic procedures. The PramStat patch is designed to bioabsorb within a week following implantation.
Amar Sawhney also founded Confluent Surgical, Ocular Therapeutix, Augmenix,, Instylla, and Rejoni among others.
FinSMEs
12/05/2023